A 16-week dance intervention appears to provide postmenopausal women with a host of benefits, including improvements in lipid profile and functional fitness, as well as in self-image and self-esteem, as reported in a study.
Majority of veterans with active opioid use disorder (OUD) and cirrhosis do not receive medication treatment, while those with alcohol use disorder, schizophrenia, and previous prescriptions for opioids were the least likely to receive such therapies despite their proven effectiveness, a US study has found.
Isolation during the COVID-19 pandemic may lead to deterioration in comorbidities and mental health, according to two studies presented at the European Society of Endocrinology virtual conference (e-ECE 2021).
Heavy alcohol use appears to be associated with initial stimulant and the rewarding effects of alcohol consumption, suggests a study. Over a 10-year period, the extent of these subjective effects has increased in individuals who developed alcohol use disorder (AUD) compared with those who did not.
Better prevention and treatment strategies are needed due to the rise in potentially dangerous drinking levels among adults, suggests a US study, which supports the validity of the World Health Organization (WHO) risk drinking levels showing clinical utility as nonabstinent drinking reduction treatment goals.
Metacognitive therapy, when incorporated in cardiac rehabilitation, is useful for managing depression and anxiety in patients with cardiovascular disease (CVD), according to the results of the PATHWAY study. This approach also confers benefits for trauma symptoms, beliefs about thinking, and unhelpful thinking styles.
In patients with schizophrenia, switching to brexpiprazole from aripiprazole or nonaripiprazole dopamine antagonists is tied to a low risk of metabolic abnormalities, hyperprolactinaemia, extrapyramidal symptoms, and QTc changes, as shown in a study.